Skip to main content

Duncan Syndrome

  • Living reference work entry
  • First Online:
Atlas of Genetic Diagnosis and Counseling
  • 114 Accesses

Abstract

In 1975, Purtilo et al. (1975) reported the Duncan pedigree in which 6 of 18 males died of a lymphoproliferative disorder. The boys, aged between 2 and 19 years, exhibited a progressive combined variable immunodeficiency disease characterized by benign or malignant proliferation of lymphocytes, histiocytosis, and alterations in concentrations of serum immunoglobulins. This condition is now known as Duncan syndrome or X-linked lymphoproliferative syndrome (XLP) which is a rare T and NK cell immune deficiency which most frequently presents as fulminant infectious mononucleosis following infection with the Epstein-Barr virus (EBV) in most affected boys, leading to death in 50 % of the cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  • Boyle, G. J., Michaels, M. G., Webber, S. A., et al. (1997). Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. The Journal of Pediatrics, 131, 309–313.

    Article  CAS  PubMed  Google Scholar 

  • Cavazzana-Calvo, M., Hacein-Bey, S., de Saint, B. G., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669–672.

    Article  CAS  PubMed  Google Scholar 

  • Coffey, A., Brooksbank, R., Brandau, O., et al. (1998). Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2- domain encoding gene. Nature Genetics, 20, 129–135.

    Article  CAS  PubMed  Google Scholar 

  • Collins, M. H., Montone, K. T., Leahey, A. M., et al. (2001). Autopsy pathology of pediatric posttransplant lymphoproliferative disorder. Pediatrics, 107, E89.

    Article  CAS  PubMed  Google Scholar 

  • Conley, M. E., Notarangelo, L. D., & Etzioni, A. (1999). Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical Immunology, 93, 190–197.

    Article  CAS  PubMed  Google Scholar 

  • Filipovich, A., Johnson, J., Zhang, K., et al. (2013). Lymphoproliferative disease, X-linked [Duncan disease, XLPD]. Gene Review. Retrieved 19 Sept 2013. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1406/

  • Gaspar, H. B., Sharifi, R., Gilmour, K. C., et al. (2002). X-linked lymphoproliferative disease: Clinical, diagnostic and molecular perspective [Review]. British Journal of Haematology, 119, 585–595.

    Article  CAS  PubMed  Google Scholar 

  • Gross, T. G., Filipovich, A. H., Conley, M. E., et al. (1996). Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): Report from the XLP registry. Bone Marrow Transplantation, 17, 741–744.

    CAS  PubMed  Google Scholar 

  • Harrington, D. S., Weisenburger, D. D., & Purtilo, D. T. (1987). Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer, 59, 1419–1429.

    Article  CAS  PubMed  Google Scholar 

  • Henter, J. I., Arico, M., Egeler, R. M., et al. (1997). HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Medical and Pediatric Oncology, 28, 342–347.

    Article  CAS  PubMed  Google Scholar 

  • Ho, M., Jaffe, R., Miller, G., et al. (1988). The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation, 45, 719–727.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lankester, A. C., Visser, L. F. A., Hartwig, N. G., et al. (2005). Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: Two cases in one family and review of the literature. Bone Marrow Transplantation, 36, 99–105.

    Article  CAS  PubMed  Google Scholar 

  • Latour, S., & Veillette, A. (2003). Molecular and immunological basis of X-linked lymphoproliferative disease. Immunological Reviews, 192, 212–224.

    Article  CAS  PubMed  Google Scholar 

  • Marsh, R. A., Madden, L., Kitchen, B. J., et al. (2010). XIAP deficiency: A unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood, 19, 1079–1082.

    Article  Google Scholar 

  • Milone, M. C., Tsai, D. E., Hodinka, R. L., et al. (2005). Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood, 105, 994–996.

    Article  CAS  PubMed  Google Scholar 

  • Morra, M., Howie, D., Grande, M. S., et al. (2001). X-linked lymphoproliferative disease: A progressive immunodeficiency. Annual Review of Immunology, 19, 657–682.

    Article  CAS  PubMed  Google Scholar 

  • Nalesnik, M. A., Rao, A. S., Rurukawa, H., et al. (1997). Autologous lymphokine activated killer cell therapy of Epstein-Bar virus-positive and – Negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation, 63, 1200–1205.

    Article  CAS  PubMed  Google Scholar 

  • Nichols, K. E., Ma, C. S., Cannons, J. L., et al. (2005). Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunological Reviews, 203, 180–199.

    Article  CAS  PubMed  Google Scholar 

  • Pachlopnik Schmid, J., Canioni, D., Moshous, D., et al. (2011). Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood, 117, 1522–1529.

    Article  PubMed  Google Scholar 

  • Pracher, E., Panzer-Grumayer, E. R., Zoubek, A., et al. (1994). Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplantation, 13, 655–658.

    CAS  PubMed  Google Scholar 

  • Purtilo, D. T., Cassel, C. K., Yang, J. P., et al. (1975). X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet, 1, 935–940.

    Article  CAS  PubMed  Google Scholar 

  • Purtilo, D. T., Sakamoto, K., Barnabei, V., et al. (1982). Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): Update on studies of the registry. The American Journal of Medicine, 73, 49–56.

    Article  CAS  PubMed  Google Scholar 

  • Salzer, U., Hagena, T., Webster, D. B., et al. (2008). Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency. International Archives of Allergy and Immunology, 147, 147–151.

    Article  CAS  PubMed  Google Scholar 

  • Sayos, J., Wu, C., Morra, M., et al. (1998). The X-linked lymphoproliferative disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature, 395, 462–469.

    Article  CAS  PubMed  Google Scholar 

  • Seiter, K. (2015). X-linked lymphoproliferative syndrome. eMedicine from WebMD. Updated 26 Nov 2015. Available at: http://emedicine.medscape.com/article/203780-overview

  • Sullivan, J. L., & Woda, B. A. (1989). X-linked lymphoproliferative syndrome. Immunodeficiency Reviews, 1, 325–347.

    CAS  PubMed  Google Scholar 

  • Sumegi, J., Huang, D., Lanyi, A., et al. (2000). Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood, 96, 3118–3125.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harold Chen .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this entry

Cite this entry

Chen, H. (2016). Duncan Syndrome. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_71-2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6430-3_71-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6430-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics